Association of Cholelithiasis after Diagnosis of Non-Alcoholic Chronic Liver Disease on Ultrasound
DOI:
https://doi.org/10.70749/ijbr.v3i2.655Keywords:
Cholelithiasis, Chronic Liver Disease, Gallstones, Hepatobiliary Ultrasound, Prevalence, Non-Alcoholic Fatty Liver Disease (NAFLD), Hepatic Cirrhosis, Risk FactorsAbstract
Background: Cholelithiasis is a common hepatobiliary disorder characterized by gallstone formation, frequently observed in patients with chronic liver disease (CLD). Hepatic dysfunction alters bile composition and motility, increasing the risk of gallstone development. The prevalence of gallstones among CLD patients varies across populations, necessitating further investigation. Objective: To determine the prevalence of cholelithiasis among patients with non-alcoholic CLD and assess its association with demographic factors such as age and gender. Methods: A cross-sectional study was conducted at the Radiology Department of WAPDA Hospital, Lahore over period of 6 months from April 2024 to August 2024, on 108 patients diagnosed with non-alcoholic CLD. Standardized ultrasound imaging was performed using a Toshiba AplioMx system with a 3–6 MHz transducer. The study population was selected through random sampling, and data were analyzed using IBM SPSS v25. Descriptive statistics, chi-square tests, and prevalence calculations were applied. A p-value ≤0.05 was considered statistically significant. Results: Among the 108 participants, 71 (65.7%) were male and 37 (34.3%) were female. Cholelithiasis was detected in 73 (67.6%) patients. Chi-square analysis showed no significant association between gender and gallstone presence (χ²=0.021, p=0.885). Conclusion: A high prevalence of cholelithiasis was observed in non-alcoholic CLD patients, emphasizing the need for routine hepatobiliary screening to prevent complications.
Downloads
References
Lin, A., Roth, H., Anyane-Yeboa, A., Rubin, D. T., & Paul, S. (2020). Prevalence of nonalcoholic fatty liver disease in patients with inflammatory bowel disease: A systematic review and meta-analysis. Inflammatory Bowel Diseases, 27(6), 947-955. https://doi.org/10.1093/ibd/izaa189
Alsaif, F., Alqahtani, S., Alsadoon, A., Alswat, K., Abdo, A., Hassanain, M., Alsharabi, A., Aljuhani, G., Alkhalidi, H., Elsharkawy, M., Alotaibi, M., Sanai, F., & Al-hamoudi, W. (2020). Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease. Saudi Journal of Gastroenterology, 26(4), 204. https://doi.org/10.4103/sjg.sjg_29_20
Latenstein, C. S., Alferink, L. J., Darwish Murad, S., Drenth, J. P., Van Laarhoven, C. J., & De Reuver, P. R. (2020). The association between cholecystectomy, metabolic syndrome, and nonalcoholic fatty liver disease: A population-based study. Clinical and Translational Gastroenterology, 11(4), e00170. https://doi.org/10.14309/ctg.0000000000000170
Rodríguez-Antonio, I., López-Sánchez, G. N., Garrido-Camacho, V. Y., Uribe, M., Chávez-Tapia, N. C., & Nuño-Lámbarri, N. (2020). Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development. HPB, 22(11), 1513-1520. https://doi.org/10.1016/j.hpb.2020.07.011
Paik, J. M., Golabi, P., Younossi, Y., Mishra, A., & Younossi, Z. M. (2020). Changes in the global burden of chronic liver diseases from 2012 to 2017: The growing impact of NAFLD. Hepatology, 72(5), 1605-1616. https://doi.org/10.1002/hep.31173
Sepehrimanesh, M., Niknam, R., Ejtehadi, F., Fattahi, M. R., & Safarpour, A. (2020). Association Between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome with Gallstone Disease, South Iran : A Population-Based Study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 1449-1458. https://doi.org/10.2147/dmso.s246949
Cherkashchenko, N. A., Livzan, M. A., & Krolevets, T. S. (2020). Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease. Terapevticheskii arkhiv, 92(2), 48-54. https://doi.org/10.26442/00403660.2020.02.000550
Corrao, S., Natoli, G., & Argano, C. (2020). Nonalcoholic fatty liver disease is associated with intrahepatic cholangiocarcinoma and not with extrahepatic form: Definitive evidence from meta-analysis and trial sequential analysis. European Journal of Gastroenterology & Hepatology, 33(1), 62-68. https://doi.org/10.1097/meg.0000000000001684
Shen, S. S., Gong, J. J., Wang, X. W., Chen, L., Qin, S., Huang, L. F., ... & Hu, H. D. (2017). Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: A systematic review and meta-analysis. Turk J Gastroenterol, 28(1), 31-39. https://turkjgastroenterol.org/content/files/sayilar/296/buyuk/31-91.pdf
Liu, S., Ma, X., Zhao, J., Du, S., Zhang, J., Dong, M., & Xin, Y. (2020). Association between nonalcoholic fatty liver disease and extrahepatic cancers: A systematic review and meta-analysis. Lipids in Health and Disease, 19(1). https://doi.org/10.1186/s12944-020-01288-6
Younossi, Z. M., Noureddin, M., Bernstein, D., Kwo, P., Russo, M., Shiffman, M. L., Younes, Z., & Abdelmalek, M. (2020). Role of Noninvasive tests in clinical gastroenterology practices to identify patients with nonalcoholic Steatohepatitis at high risk of adverse outcomes: Expert panel recommendations. American Journal of Gastroenterology, 116(2), 254-262. https://doi.org/10.14309/ajg.0000000000001054
Kichloo, A., Solanki, S., Haq, K. F., Dahiya, D., Bailey, B., Solanki, D., Singh, J., Albosta, M., Wani, F., Aljadah, M., Shah, H., Khan, H., & Jafri, S. (2021). Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population. World Journal of Gastrointestinal Pathophysiology, 12(2), 14-24. https://doi.org/10.4291/wjgp.v12.i2.14
De, A., Ahmad, N., Mehta, M., Singh, P., & Duseja, A. (2022). NAFLD vs. MAFLD – It is not the name but the disease that decides the outcome in fatty liver. Journal of Hepatology, 76(2), 475-477. https://doi.org/10.1016/j.jhep.2021.09.002
Mallick, B., & Anand, A. C. (2022). Gallstone disease in cirrhosis—Pathogenesis and management. Journal of Clinical and Experimental Hepatology, 12(2), 551-559. https://doi.org/10.1016/j.jceh.2021.09.011
Rodríguez-Antonio, I., López-Sánchez, G. N., Reyes-Gómez, V. A., Contreras-Flores, E. H., Farías-García, F., Espejel-Deloiza, M., Durán-Padilla, M. A., Chablé-Montero, F., Uribe, M., Chávez-Tapia, N. C., Montalvo-Javé, E. E., & Nuño-Lámbarri, N. (2022). Laparoscopic cholecystectomy: Histopathological analysis of metabolic associated fatty liver disease and fibrosis. Annals of Hepatology, 27(2), 100651. https://doi.org/10.1016/j.aohep.2021.100651
Park, J., Hong, J. Y., Kwon, M., Lee, J., Han, K., Han, I. W., Kang, W., & Park, J. K. (2021). Association between non-alcoholic fatty liver disease and the risk of biliary tract cancers: A South Korean nationwide cohort study. European Journal of Cancer, 150, 73-82. https://doi.org/10.1016/j.ejca.2021.03.024
Chen, L., Yang, H., Li, H., He, C., Yang, L., & Lv, G. (2021). Insights into modifiable risk factors of cholelithiasis: A mendelian randomization study. Hepatology, 75(4), 785-796. https://doi.org/10.1002/hep.32183
Premkumar, M., & Anand, A. C. (2021). Tobacco, cigarettes, and the liver: The smoking gun. Journal of Clinical and Experimental Hepatology, 11(6), 700-712. https://doi.org/10.1016/j.jceh.2021.07.016
Mekhtiev, S., Mekhtieva, O., Ukhova, M., & Ibragimova, Z. (2021). Modern view of the importance of cholecystectomy in the prognosis of a patient with non-alcoholic fatty liver disease: Follow-up algorithm and therapeutic approaches. Russian Medical Inquiry, 5(6), 438-445. https://doi.org/10.32364/2587-6821-2021-5-6-438-445
Sbeit, W., Sbeit, M., Kalisky, I., Katz, L., Mari, A., & Khoury, T. (2021). The possible association of non-alcoholic fatty liver disease with acute Cholangitis: A retrospective multicenter cohort study. Life, 12(1), 35. https://doi.org/10.3390/life12010035
Lu, Y., Hu, L., Song, J., Wan, J., Chen, H., & Yin, J. (2021). Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: A cross-sectional study. BMC Endocrine Disorders, 21(1). https://doi.org/10.1186/s12902-021-00899-z
Soomro, A. H., Iqbal, J., Bhatti, R., Naz, F., Arsalan, M., & Memon, M. S. (2022). Association of non-alcoholic fatty liver disease with symptomatic and asymptomatic cholelithiasis: Cohort from Southeast Asian patients. Journal of Pharmaceutical Research International, 50-57. https://doi.org/10.9734/jpri/2022/v34i14a35647
Sun, H., Warren, J., Yip, J., Ji, Y., Hao, S., Han, W., & Ding, Y. (2022). Factors influencing gallstone formation: A review of the literature. Biomolecules, 12(4), 550. https://doi.org/10.3390/biom12040550
Konyn, P., Alshuwaykh, O., Dennis, B. B., Cholankeril, G., Ahmed, A., & Kim, D. (2023). Gallstone disease and its association with nonalcoholic fatty liver disease, all-cause and cause-specific mortality. Clinical Gastroenterology and Hepatology, 21(4), 940-948.e2. https://doi.org/10.1016/j.cgh.2022.04.043
Krolevets, T., Livzan, M., Syrovenko, M., & Cherkashchenko, N. (2022). Pathogenic aspects of the comorbid course of non-alcoholic fatty liver disease and cholelithiasis: A review and the authors’ results. Russian Medical Inquiry, 6(5), 278-285. https://doi.org/10.32364/2587-6821-2022-6-5-278-285
Luo, D., Chen, X., Dai, Y., Kuang, F., Kang, M., Li, B., & Su, S. (2023). Cholecystectomy and risk of liver disease: A systematic review and meta-analysis of 27 million individuals. International Journal of Surgery, 109(5), 1420-1429. https://doi.org/10.1097/js9.0000000000000332
Slouha, E., Biput, S. J., Kalloo, A. E., & Gorantla, V. R. (2023). Non-alcoholic fatty liver disease and gallstones: a systematic review. Cureus, 15(9).
Abenavoli, L., Spagnuolo, R., Scarlata, G. G., Scarpellini, E., Boccuto, L., & Luzza, F. (2023). Ultrasound prevalence and clinical features of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A real-life cross-sectional study. Medicina, 59(11), 1935. https://doi.org/10.3390/medicina59111935
Patel, P., Inayat, F., Ali, H., Afzal, A., Taj, S., Rehman, A. U., Hussain, N., Ishtiaq, R., Nawaz, G., Afzal, M. S., Fatakhova, K., & Satapathy, S. K. (2023). Association of nonalcoholic fatty liver disease with acute cholangitis: A nationwide propensity-matched analysis from the United States. Baylor University Medical Center Proceedings, 36(5), 600-607. https://doi.org/10.1080/08998280.2023.2231721
Gu, S., Hu, S., Wang, S., Qi, C., Shi, C., & Fan, G. (2023). Bidirectional association between NAFLD and gallstone disease: A systematic review and meta-analysis of observational studies. Expert Review of Gastroenterology & Hepatology, 17(3), 283-293. https://doi.org/10.1080/17474124.2023.2175671
Jafar, Z. S., Ahmed, A., Akram, M. N., Mirza, M. J., & Ahtesham, K. (2023). Frequency of non-alcoholic fatty liver disease (Nafld) and its association with diabetes mellitus, hypertension and cholelithiasis among patients undergoing routine ultrasonography. JAIMC: Journal of Allama Iqbal Medical College, 20(2). https://doi.org/10.59058/jaimc.v20i2.36
Su, Y., Lin, S., & Chen, Y. (2024). Causal effects from nonalcoholic fatty liver disease on cholelithiasis: A mendelian randomization study. Health Science Reports, 7(3). https://doi.org/10.1002/hsr2.1987
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research

This work is licensed under a Creative Commons Attribution 4.0 International License.